Press Releases Hemostemix Inc.

Equities

HEM

CA4236943060

Market Closed - Toronto S.E. Other stock markets 20:47:51 25/06/2024 BST			5-day change	1st Jan Change
0.04 ^CAD	-11.11%		-27.27%	-42.86%

06-11	Hemostemix Announces Strategic Manufacturing Partnership with Cytoimmune Therapuetics	CI
06-03	Hemostemix Inc. announced that it expects to receive CAD 2 million in funding	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hemostemix Announces Trademark Granted by Switzerland and Interest Payment	06-11	NE
Hemostemix Announces Strategic Manufacturing Partnership with CytoImmune Therapeutics and $1,800,000 in Financing Commitments	06-03	NE
Hemostemix Announces Engagement of Oak Hill Asset Management Inc.	03-07	NE
Hemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental Sciences	02-06	NE
Hemostemix Clarifies its October 3, 2023 News Release	12-29	NE
Hemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart Disease	30/10/23	NE
Hemostemix Announces Amendment of its $2.5 Million 5 Year Convertible Debenture Issued on June 11, 2021, Resulting in an Expected Interest Saving of Approximately $570,000	23/10/23	NE
Hemostemix Closed $320,125 Private Placement	03/10/23	NE
Hemostemix Announces Private Placement	27/09/23	NE
Hemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant Applications	30/08/23	AQ
Hemostemix Announces Arbitration Award of CAD $315,684 Plus Private Placement	15/08/23	AQ
The Benefits of ACP-01 Stem Cell Therapy: Can it Save Limbs and thereby Lives	06/07/23	PU
Hemostemix : Benefits of Stem Cell Therapy and How it Can Save Lives	05/07/23	PU
Hemostemix : 2021/2022 Consolidated Financial Statements	08/05/23	PU
Hemostemix : Notice of Annual and Special Meeting of Shareholders	08/05/23	PU
IIROC Trading Resumption - HEM	02/05/23	AQ
IIROC Trading Halt - HEM	02/05/23	AQ
Hemostemix Second Round Interviews with Executive Vice President Business Development Candidates	04/04/23	AQ
Hemostemix Engages Montreal's RobboDesign to SEO its Website to Engage with 236 Million Peripheral Arterial Disease and Critical Limb Ischemia Patients Globally	30/03/23	AQ
HEMOSTEMIX CLOSES $762,400 OF THE UNIT PRIVATE PLACEMENT	22/03/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Hemostemix Inc.

Equities

HEM

CA4236943060

Press Releases

Filters